Finanzwire Finanzwire
Basculer en Français
11154 Companies
246145 Keywords
174144 Articles
132910 Press releases
Headlines Articles Press releases Epitome Therapeutics FlexCo Remove
  1. Home
  2. Companies
  3. Epitome Therapeutics FlexCo
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/30/2026 at 09:05, 3 months 11 days ago

    Epitome Therapeutics Secures €4 Million in Funding

    Biotechnology Funding Precision Medicine Gene Expression Epigenome Editing
  • PRESS RELEASE

    published on 06/30/2026 at 09:00, 3 months 11 days ago

    Epitome Therapeutics Launches with €4 Million in Total Funding Following Oversubscribed Pre-Seed Round

    Epitome Therapeutics launches with €4 million in total funding following oversubscribed pre-seed round, developing next-generation epigenome editing platform for gene expression regulation
    Funding Gene Expression Epitome Therapeutics Pre-seed Round CADENCE Platform
    Logo of Epitome Therapeutics FlexCo
Accesswire
  • Published on 10/10/2026 at 04:45, 2 days 2 hours ago

    Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV

  • Published on 10/10/2026 at 02:03, 2 days 5 hours ago

    BrandPilot AI Announces Closing of Previously Announced Debt Settlement

  • Published on 10/10/2026 at 02:00, 2 days 5 hours ago

    Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology

  • Published on 10/09/2026 at 23:00, 2 days 8 hours ago

    Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720

  • Published on 10/09/2026 at 22:15, 2 days 8 hours ago

    Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call

View all ACCESSWIRE
EQS Group
  • Published on 10/12/2026 at 07:00, 12 minutes ago

    EvoNext Holdings SA and Ascend Sport Technology AG sign transaction agreement

  • Published on 10/12/2026 at 07:00, 12 minutes ago

    Nordex Group order intake rises 29.5% to 2.8 GW in the third quarter of 2026

  • Published on 10/12/2026 at 06:30, 42 minutes ago

    Centiel obtains UL certification and receives USD 51 million U.S. purchase order; U.S. deliveries expected in 2027 and 2026 guidance revised

  • Published on 10/12/2026 at 06:05, 1 hour 6 minutes ago

    SWI Group announces €800 million institutional capital increase at a €6.1 billion final valuation to accelerate the expansion of its transatlantic AI infrastructure and compute platform

  • Published on 10/12/2026 at 05:00, 2 hours 12 minutes ago

    ATOMS, Led by Travis Kalanick, Secures $1.7B to Power the Future of Food Delivery with ProKitchens in Europe

View all EQS
Les Echos
  • Published on 10/09/2026 at 19:27, 2 days 11 hours ago

    Disclosure of transactions in own shares from October 1 to October 9, 2026

  • Published on 10/09/2026 at 18:01, 2 days 13 hours ago

    Title of my press release

  • Published on 10/08/2026 at 18:30, 3 days 12 hours ago

    Cegedim: Release of its 2026 Interim Financial Report

  • Published on 10/08/2026 at 18:00, 3 days 13 hours ago

    Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years

  • Published on 10/08/2026 at 17:45, 3 days 13 hours ago

    Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy